Subcutaneous daratumumab plus carfilzomib and dexamethasone (D-Kd) versus carfilzomib and dexamethasone (Kd) in patients with relapsed/refractory multiple myeloma who received previous daratumumab treatment: LYNX study.
Saved in:
| Title: | Subcutaneous daratumumab plus carfilzomib and dexamethasone (D-Kd) versus carfilzomib and dexamethasone (Kd) in patients with relapsed/refractory multiple myeloma who received previous daratumumab treatment: LYNX study. |
|---|---|
| Authors: | Bahlis, Nizar J.1 (AUTHOR) nbahlis@ucalgary.ca, Zonder, Jeffrey2 (AUTHOR), Karlin, Lionel3 (AUTHOR), Plesner, Torben4 (AUTHOR), Paris, Laura5 (AUTHOR), Wrobel, Tomasz6 (AUTHOR), Hungria, Vania7 (AUTHOR), Besemer, Britta8 (AUTHOR), Crusoe, Edvan9 (AUTHOR), Silkjaer, Trine10 (AUTHOR), Perrot, Aurore11 (AUTHOR), Moreau, Philippe12 (AUTHOR), Wu, Ka Lung13 (AUTHOR), Delimpasi, Sosana14 (AUTHOR), Dimopoulos, Meletios A.15,16 (AUTHOR), Levin, Mark-David17 (AUTHOR), Mangiacavalli, Silvia18 (AUTHOR), Nnane, Ivo19 (AUTHOR), Kim, Yu Jin20 (AUTHOR), Krevvata, Maria19 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Dec2025, Vol. 66 Issue 14, p2685-2696. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 190255941 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Subcutaneous daratumumab plus carfilzomib and dexamethasone (D-Kd) versus carfilzomib and dexamethasone (Kd) in patients with relapsed/refractory multiple myeloma who received previous daratumumab treatment: LYNX study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Bahlis%2C+Nizar+J%2E%22">Bahlis, Nizar J.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> nbahlis@ucalgary.ca</i><br /><searchLink fieldCode="AR" term="%22Zonder%2C+Jeffrey%22">Zonder, Jeffrey</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Karlin%2C+Lionel%22">Karlin, Lionel</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Plesner%2C+Torben%22">Plesner, Torben</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Paris%2C+Laura%22">Paris, Laura</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wrobel%2C+Tomasz%22">Wrobel, Tomasz</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hungria%2C+Vania%22">Hungria, Vania</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Besemer%2C+Britta%22">Besemer, Britta</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Crusoe%2C+Edvan%22">Crusoe, Edvan</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Silkjaer%2C+Trine%22">Silkjaer, Trine</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Perrot%2C+Aurore%22">Perrot, Aurore</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Moreau%2C+Philippe%22">Moreau, Philippe</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Ka+Lung%22">Wu, Ka Lung</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Delimpasi%2C+Sosana%22">Delimpasi, Sosana</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dimopoulos%2C+Meletios+A%2E%22">Dimopoulos, Meletios A.</searchLink><relatesTo>15,16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Levin%2C+Mark-David%22">Levin, Mark-David</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mangiacavalli%2C+Silvia%22">Mangiacavalli, Silvia</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nnane%2C+Ivo%22">Nnane, Ivo</searchLink><relatesTo>19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kim%2C+Yu+Jin%22">Kim, Yu Jin</searchLink><relatesTo>20</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Krevvata%2C+Maria%22">Krevvata, Maria</searchLink><relatesTo>19</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Leukemia+%26+Lymphoma%22">Leukemia & Lymphoma</searchLink>. Dec2025, Vol. 66 Issue 14, p2685-2696. 12p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=190255941 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/10428194.2025.2561117 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 12 StartPage: 2685 Titles: – TitleFull: Subcutaneous daratumumab plus carfilzomib and dexamethasone (D-Kd) versus carfilzomib and dexamethasone (Kd) in patients with relapsed/refractory multiple myeloma who received previous daratumumab treatment: LYNX study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bahlis, Nizar J. – PersonEntity: Name: NameFull: Zonder, Jeffrey – PersonEntity: Name: NameFull: Karlin, Lionel – PersonEntity: Name: NameFull: Plesner, Torben – PersonEntity: Name: NameFull: Paris, Laura – PersonEntity: Name: NameFull: Wrobel, Tomasz – PersonEntity: Name: NameFull: Hungria, Vania – PersonEntity: Name: NameFull: Besemer, Britta – PersonEntity: Name: NameFull: Crusoe, Edvan – PersonEntity: Name: NameFull: Silkjaer, Trine – PersonEntity: Name: NameFull: Perrot, Aurore – PersonEntity: Name: NameFull: Moreau, Philippe – PersonEntity: Name: NameFull: Wu, Ka Lung – PersonEntity: Name: NameFull: Delimpasi, Sosana – PersonEntity: Name: NameFull: Dimopoulos, Meletios A. – PersonEntity: Name: NameFull: Levin, Mark-David – PersonEntity: Name: NameFull: Mangiacavalli, Silvia – PersonEntity: Name: NameFull: Nnane, Ivo – PersonEntity: Name: NameFull: Kim, Yu Jin – PersonEntity: Name: NameFull: Krevvata, Maria IsPartOfRelationships: – BibEntity: Dates: – D: 20 M: 12 Text: Dec2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 10428194 Numbering: – Type: volume Value: 66 – Type: issue Value: 14 Titles: – TitleFull: Leukemia & Lymphoma Type: main |
| ResultId | 1 |